Pengaruh Kadar High Density Lipoprotein (HDL) dan Usia terhadap Kejadian Peripheral Arterial Disease (PAD)
DOI:
https://doi.org/10.55606/termometer.v1i3.2059Keywords:
age, high-density lipoprotein, peripheral arterial diseaseAbstract
Peripheral arterial disease is a disease that will cause circulatory problem, causing reduction of blood flow inside the artery. This disease approximately has by 6.5 million people above 40 years of age in the United State, and is expected to double with each decade. There are many risk factors for this disease, which includes dyslipidemia and age. High-density lipoprotein (HDL) is one of the lipid component that affects dyslipidemia. This study aims to find out the effects of HDL and age to peripheral arterial disease incidence. The study was done in Yayasan Kalam Kudus, Jakarta on 02 June 2023, with the sample of people aged 18-60 years old, with non-randomized consecutive sampling method. The exclusion criteria on this study are respondents who refused to participate in the study, respondents who are amputated, respondents who has ulcer on the foot, and respondents with ankle-branchial index (ABI) above 1,3. The analysis done in this study are descriptive analysis as in proportion and distribution of centralized data, and analytic analysis using independent T-test and Mann Whitney test as an alternative test, with significance value of 5% (p-value = <0.05). Normality test was done before statistical analysis. From the study, we found out that age is significant role statistically in the incidence of peripheral arterial disease (p-value: 0.028), but levels of HDL are not statistically significant with the incidence of peripheral arterial disease (p-value: 0.084).
References
Abola, M. T. B., Golledge, J., Miyata, T., Rha, S.-W., Yan, B. P., Dy, T. C., Ganzon, M. S. V, Handa, P. K., Harris, S., Zhisheng, J., Pinjala, R., Robless, P. A., Yokoi, H., Alajar, E. B., Santos, A. A. B., Llanes, E. J. B., Obrado-Nabablit, G. M., Pestaño, N. S., Punzalan, F. E., … Punzalan, F. E. (2020). Asia-Pacific Consensus Statement on the Management of Peripheral Artery Disease: A Report from the Asian Pacific Society of Atherosclerosis and Vascular Disease Asia-Pacific Peripheral Artery Disease Consensus Statement Project Committee. Journal of Atherosclerosis and Thrombosis, 27(8), 809. https://doi.org/10.5551/JAT.53660
Aday, A. W., & Everett, B. M. (2019). Dyslipidemia Profiles in Patients with Peripheral Artery Disease. Current Cardiology Reports, 21(6), 42. https://doi.org/10.1007/S11886-019-1129-5
Aday, A. W., & Matsushita, K. (2021). Epidemiology of Peripheral Artery Disease and Polyvascular Disease: Aday – Epidemiology of PAD. Circulation Research, 128(12), 1818. https://doi.org/10.1161/CIRCRESAHA.121.318535
Aryani, E., Heri-Nugroho, H.-N., & Margawati, A. (2016). HUBUNGAN ANTARA DISLIPIDEMIA DENGAN STATUS PENYAKIT ARTERI PERIFER (PAP) PADA PASIEN DIABETES MELITUS TIPE 2 TERKONTROL SEDANG. Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal), 5(4), 720–736. https://doi.org/10.14710/DMJ.V5I4.14339
Criqui, M. H., & Aboyans, V. (2015). Epidemiology of peripheral artery disease. Circulation Research, 116(9), 1509–1526. https://doi.org/10.1161/CIRCRESAHA.116.303849
Criqui, M. H., Matsushita, K., Aboyans, V., Hess, C. N., Hicks, C. W., Kwan, T. W., McDermott, M. M., Misra, S., Ujueta, F., & on behalf of the American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, T. and V. B. C. on C. R. and I. C. on L. and C. H. C. on P. V. D. and S. C. (2021). Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association. Circulation, 144, E171–E191. https://doi.org/10.1161/CIR.0000000000001005
D’Agostino, R. B., Pencina, M. J., Massaro, J. M., & Coady, S. (2013). Cardiovascular Disease Risk Assessment: Insights from Framingham. Global Heart, 8(1), 11–23. https://doi.org/10.1016/j.gheart.2013.01.001
de Macedo Ribeiro, F. R. C., Ribeiro, C. H. M. A., Tavoni, T. M., Dos Santos Sarges, E., Freitas, F. R., Stolf, N. A. G., Kalil Filho, R., & Maranhão, R. C. (2021). Disturbances of the transfer of cholesterol to high-density lipoprotein (HDL) in patients with peripheral artery disease with or without type 2 diabetes mellitus. Vascular Medicine (London, England), 26(6), 602–607. https://doi.org/10.1177/1358863X211021142
Hennion, D. R., & Siano, K. A. (2013). Diagnosis and treatment of peripheral arterial disease. American Family Physician, 88(5), 306–310.
Kosmas, C. E., Martinez, I., Sourlas, A., Bouza, K. V, Campos, F. N., Torres, V., Montan, P. D., & Guzman, E. (2018). High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease. Drugs in Context, 7, 212525. https://doi.org/10.7573/dic.212525
Rac-Albu, M., Iliuta, L., Guberna, S. M., & Sinescu, C. (2014). The role of ankle-brachial index for predicting peripheral arterial disease. Maedica, 9(3), 295–302.
Rosenson, R. S., Brewer, H. B., Ansell, B. J., Barter, P., Chapman, M. J., Heinecke, J. W., Kontush, A., Tall, A. R., & Webb, N. R. (2016). Dysfunctional HDL and atherosclerotic cardiovascular disease. Nature Reviews. Cardiology, 13(1), 48–60. https://doi.org/10.1038/nrcardio.2015.124
Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., Bonny, A., Brauer, M., Brodmann, M., Cahill, T. J., Carapetis, J., Catapano, A. L., Chugh, S. S., Cooper, L. T., Coresh, J., … Fuster, V. (2020). Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. Journal of the American College of Cardiology, 76(25), 2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010
Savji, N., Rockman, C. B., Skolnick, A. H., Guo, Y., Adelman, M. A., Riles, T., & Berger, J. S. (2013). Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. Journal of the American College of Cardiology, 61(16), 1736–1743. https://doi.org/10.1016/j.jacc.2013.01.054
Shu, J., & Santulli, G. (2018). Update on peripheral artery disease: Epidemiology and evidence-based facts. Atherosclerosis, 275, 379–381. https://doi.org/10.1016/j.atherosclerosis.2018.05.033
Simatupang, M., Pandelaki, K., Panda, A. L., Skripsi Fakultas Kedokteran Universitas Sam Ratulangi Manado, K., & Ilmu Penyakit Dalam RSUP Kandau Manado, B. R. (2013). HUBUNGAN ANTARA PENYAKIT ARTERI PERIFER DENGAN FAKTOR RISIKO KARDIOVASKULAR PADA PASIEN DM TIPE 2. E-CliniC, 1(1). https://doi.org/10.35790/ECL.V1I1.1179
Sykora, D., Firth, C., Girardo, M., Bhatt, S., Matti, L., Tseng, A., Shipman, J., Liedl, D., Wennberg, P., & Shamoun, F. E. (2022). Patient Age at Diagnosis of Peripheral Artery Disease and Its Impact on Cardiovascular and Limb Outcomes. The American Journal of Cardiology, 177, 144–150. https://doi.org/10.1016/j.amjcard.2022.04.057
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., Elkind, M. S. V., Evenson, K. R., Ferguson, J. F., Gupta, D. K., Khan, S. S., Kissela, B. M., Knutson, K. L., Lee, C. D., Lewis, T. T., … Tsao, C. W. (2021). Heart Disease and Stroke Statistics - 2021 Update: A Report From the American Heart Association. Circulation, 143(8), E254–E743. https://doi.org/10.1161/CIR.0000000000000950
Zemaitis, M. R., Boll, J. M., & Dreyer, M. A. (2023). Peripheral Arterial Disease. StatPearls.
Zierfuss, B., Höbaus, C., Herz, C. T., Koppensteiner, R., Stangl, H., & Schernthaner, G.-H. (2022). High-Density Lipoprotein Particle Subclasses in Statin-Treated Patients with Peripheral Artery Disease Predict Long-Term Survival. Thrombosis and Haemostasis, 122(10), 1804–1813. https://doi.org/10.1055/a-1827-7896
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Daniel Ruslim, Edwin Destra, Joshua Kurniawan, Yohanes Firmansyah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
